Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a complex organic molecule featuring two difluoro-methylphosphonic acid moieties linked by a phenyl-butyl-phenyl chain. Phosphonic acid derivatives are widely utilized in drug discovery as stable bioisosteres for phosphate groups, enabling them to interact with enzymes that typically bind phosphates or to target bone tissue. While the specific mechanism of action and therapeutic indications for this exact compound are not publicly documented, related phosphonic acid compounds have demonstrated activity as enzyme inhibitors (e.g., PTP1B inhibitors) and as antiviral agents. The presence of the difluoro-methyl group can influence the compound's metabolic stability and binding properties. This structure suggests potential for strong binding interactions, characteristic of phosphonic acid-containing drugs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on [(4-{4-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Butyl}-Phenyl)-Difluoro-Methyl]-Phosphonic Acid.